A/Prof. Irina Caminschi and Prof. Tony Purcell, Monash University, Melbourne, A/Prof. Paul Leo, QUT, Dr. Ian Bennett, Princes Alexandra Hospital, Dr. Natasha Woodward, Mater Hospital. Project aiming at characterizing the role of neo-antigen immune responses in mouse and human breast cancer.
A/Prof Michael Kershaw, Peter MacCallum/Victorian Comprehensive Cancer Centre, Melbourne. Project aiming at exploiting our Clec9A-targeting vaccination platform to enhance co-stimulation and in vivo persistence of CAR-T cells with dual specificity.
Prof. Nicholas Hayward, Dr. Nic Waddel, Dr. Michele Teng, QIMR-B. Project aiming at characterizing the immunogenicity of acral melanomas.
A/Prof. A. Barbour, Princess Alexandra Hospital. Project aiming at characterising tumour neo-antigen-specific immune responses in oesophageal adenocarcinoma patients with long-term survival.
Merck, Sharp & Dohme Corp. Inc. Project aiming at promoting further development of the self-adjuvanting vaccination platform developed at UQDI in close collaboration with Prof. Ranjeny Thomas.
